These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1387869)

  • 1. Deoxyspergualin, a novel immunosuppressant, markedly inhibits human mixed lymphocyte reaction and cytotoxic T-lymphocyte activity in vitro.
    Fujii H; Takada T; Nemoto K; Abe F; Fujii A; Talmadge JE; Takeuchi T
    Int J Immunopharmacol; 1992 May; 14(4):731-7. PubMed ID: 1387869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro kinetic study of the immunosuppressive effect of deoxymethylspergualin on human peripheral blood mononuclear cells.
    Takano Y; Takahara S; Jiang H; Kameoka H; Kokado Y; Moutabarrik A; Ishibashi M; Okuyama A
    J Clin Lab Immunol; 1991 Apr; 34(4):163-9. PubMed ID: 1668283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of immunosuppressive mechanism of deoxymethylspergualin in vitro].
    Uemura T
    Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1301-7. PubMed ID: 8355445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro immunosuppressive effect: a comparative study between deoxymethylspergualin and cyclosporin A, on human lymphocyte responses.
    Jiang H; Takahara S; Kokado Y; Ishibashi M; Sonoda T
    J Clin Lab Immunol; 1990 Oct; 33(2):75-81. PubMed ID: 1967069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vitro immunosuppressive effect of deoxymethylspergualin in man as compared with FK506 and cyclosporine.
    Takahara S; Jiang H; Takano Y; Kokado Y; Ishibashi M; Okuyama A; Sonoda T
    Transplantation; 1992 Apr; 53(4):914-8. PubMed ID: 1373537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of 15-deoxyspergualin. I. Suppressive effect on the induction of alloreactive secondary cytotoxic T lymphocytes in vivo and in vitro.
    Nishimura K; Tokunaga T
    Immunology; 1989 Sep; 68(1):66-71. PubMed ID: 2509326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 15-Deoxyspergualin inhibits interleukin 6 production in in vitro stimulated human lymphocytes.
    Borg AJ; Kumagai-Braesch M; Möller E
    Transpl Immunol; 1996 Jun; 4(2):133-43. PubMed ID: 8843590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro study of deoxymethylspergualin on functions of lymphocytes and bone marrow cells from healthy volunteers.
    Kawasaki C; Okamura S; Shimoda K; Nemoto K; Niho Y
    J Antibiot (Tokyo); 1995 Mar; 48(3):243-7. PubMed ID: 7730159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressant deoxyspergualin induces apoptotic cell death in dividing cells.
    Odaka C; Toyoda E; Nemoto K
    Immunology; 1998 Nov; 95(3):370-6. PubMed ID: 9824499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-Deoxyspergualin, a novel immunosuppressive drug: studies of the mechanism of action.
    Tepper MA; Nadler S; Mazzucco C; Singh C; Kelley SL
    Ann N Y Acad Sci; 1993 Jun; 685():136-47. PubMed ID: 8363218
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro immunosuppressive properties of spergualins to murine T cell response.
    Fujii H; Takada T; Nemoto K; Abe F; Fujii A; Takeuchi T
    J Antibiot (Tokyo); 1989 May; 42(5):788-94. PubMed ID: 2524464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunosuppressive mode of action of mizoribine.
    Ichikawa Y; Ihara H; Takahara S; Takada K; Shrestha GR; Ishibashi M; Arima M; Sagawa S; Sonoda T
    Transplantation; 1984 Sep; 38(3):262-7. PubMed ID: 6236592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deoxyspergualin inhibits cytotoxic T lymphocytes but not NK or LAK cells.
    Kerr PG; Atkins RC
    Immunol Cell Biol; 1991 Jun; 69 ( Pt 3)():177-83. PubMed ID: 1835710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of interleukin 2 on the immunosuppressive action of cyclosporine.
    Hess AD
    Transplantation; 1985 Jan; 39(1):62-8. PubMed ID: 3155579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of deoxyspergualin on lymphocytes and monocytes in vivo and in vitro.
    Kerr PG; Atkins RC
    Transplantation; 1989 Dec; 48(6):1048-52. PubMed ID: 2531949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The suppressive effect of deoxyspergualin on the differentiation of human B lymphocytes maturing into immunoglobulin-producing cells.
    Morikawa K; Oseko F; Morikawa S
    Transplantation; 1992 Sep; 54(3):526-31. PubMed ID: 1329279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppression of triptolide and its effect on skin allograft survival.
    Yang SX; Gao HL; Xie SS; Zhang WR; Long ZZ
    Int J Immunopharmacol; 1992 Aug; 14(6):963-9. PubMed ID: 1428369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deoxyspergualin preferentially inhibits the growth and maturation of anti-CD40-activated surface IgD+ B lymphocytes.
    Morikawa K; Nemoto K; Miyawaki T; Morikawa S
    Clin Exp Immunol; 1998 Jun; 112(3):495-500. PubMed ID: 9649221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of immunosuppressive pharmacological agents on the induction of cytotoxic and suppressor T lymphocytes in vitro.
    Bucy RP
    Immunopharmacology; 1988; 15(2):65-72. PubMed ID: 2967266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of phosphodiesterase 7 inhibitor ASB16165 on development and function of cytotoxic T lymphocyte.
    Kadoshima-Yamaoka K; Murakawa M; Goto M; Tanaka Y; Inoue H; Murafuji H; Hayashi Y; Nagahira K; Miura K; Nakatsuka T; Chamoto K; Fukuda Y; Nishimura T
    Int Immunopharmacol; 2009 Jan; 9(1):97-102. PubMed ID: 18992850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.